Gifu, Japan

Takashi Teraoka

This inventor holds 13 USPTO granted patents and 7 published patent applications and 7 EPO patents. Top assignees: Kyb Corporation, Kayaba Industry Company, Ltd., Kayaba Kogyo Kabushiki Kaisha. Active years: 2000-2018.

USPTO Granted Patents = 13 

% Patents Active = 69.2

 

Average Co-Inventor Count = 2.2

ph-index = 6

Forward Citations = 60(Granted Patents)


Location History:

  • Tokyo, JP (2000 - 2011)
  • Kani, JP (2015 - 2016)
  • Gifu, JP (2015 - 2018)

Company Filing History:


Years Active: 2000-2018

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Takashi Teraoka

Introduction: Takashi Teraoka, a pioneering inventor hailing from Gifu, Japan, has made significant contributions to the world of innovations with his groundbreaking ideas and inventions.

Latest Patents: Takashi Teraoka holds several patents in various fields, including technology, healthcare, and engineering. His recent patents focus on sustainable energy solutions and advanced medical devices.

Career Highlights: Throughout his illustrious career, Takashi Teraoka has been recognized for his inventive spirit and problem-solving skills. He has received numerous awards for his innovative contributions to society and has been a driving force behind several successful projects.

Collaborations: Takashi Teraoka has collaborated with leading research institutions, universities, and companies to bring his ideas to life. His ability to work in multidisciplinary teams has led to the development of cutting-edge technologies that have had a lasting impact on various industries.

Conclusion: In conclusion, Takashi Teraoka stands as a visionary inventor whose passion for innovation and dedication to creating a better world have solidified his place in the annals of history. His relentless pursuit of excellence continues to inspire future generations of inventors and innovators worldwide.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…